Cas no 1057670-48-0 (2-Chloro-5-(hydrazinylmethyl)pyridine)
2-Chloro-5-(hydrazinylmethyl)pyridine Chemical and Physical Properties
Names and Identifiers
-
- 2-Chloro-5-(hydrazinomethyl)pyridine
- 2-chloro-5-(chloromethyl)-N-(2,2-dimethylpropyl)-4-pyrimidineamine
- AG-A-02018
- (2-CHLORO-5-CHLOROMETHYL-PYRIMIDIN-4-YL)-(2,2-DIMETHYL-PROPYL)-AMINE
- CTK1G7389
- 2-chloro-5-(hydrazinylmethyl)pyridine
- 4-Pyrimidinamine, 2-chloro-5-(chloromethyl)-N-(2,2-dimethylpropyl)-
- (6-chloro-pyridin-3-ylmethyl)-hydrazine
- Pyridine, 2-chloro-5-(hydrazinylmethyl)-
- CS-0060453
- (6-chloropyridin-3-yl)methylhydrazine
- SCHEMBL18884421
- DB-149618
- AKOS006288566
- W16788
- 1057670-48-0
- MFCD08704288
- AM9754
- AS-63292
- EN300-1984947
- 2-Chloro-5-(hydrazinylmethyl)pyridine
-
- MDL: MFCD08704288
- Inchi: 1S/C6H8ClN3/c7-6-2-1-5(3-9-6)4-10-8/h1-3,10H,4,8H2
- InChI Key: NYNRZJAGUQREMC-UHFFFAOYSA-N
- SMILES: ClC1=CC=C(C=N1)CNN
Computed Properties
- Exact Mass: 157.0406750g/mol
- Monoisotopic Mass: 157.0406750g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 10
- Rotatable Bond Count: 2
- Complexity: 99
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.4
- Topological Polar Surface Area: 50.9?2
2-Chloro-5-(hydrazinylmethyl)pyridine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | P992343-10mg |
2-Chloro-5-(hydrazinylmethyl)pyridine |
1057670-48-0 | 10mg |
$ 50.00 | 2022-06-03 | ||
| TRC | P992343-50mg |
2-Chloro-5-(hydrazinylmethyl)pyridine |
1057670-48-0 | 50mg |
$ 115.00 | 2022-06-03 | ||
| TRC | P992343-100mg |
2-Chloro-5-(hydrazinylmethyl)pyridine |
1057670-48-0 | 100mg |
$ 160.00 | 2022-06-03 | ||
| Chemenu | CM466986-1g |
2-chloro-5-(hydrazinylmethyl)pyridine |
1057670-48-0 | 95%+ | 1g |
$333 | 2022-06-14 | |
| eNovation Chemicals LLC | D770288-250mg |
2-chloro-5-(hydrazinylmethyl)pyridine |
1057670-48-0 | 95% | 250mg |
$140 | 2024-06-07 | |
| eNovation Chemicals LLC | D770288-1g |
2-chloro-5-(hydrazinylmethyl)pyridine |
1057670-48-0 | 95% | 1g |
$200 | 2024-06-07 | |
| Enamine | EN300-1984947-0.05g |
2-chloro-5-(hydrazinylmethyl)pyridine |
1057670-48-0 | 0.05g |
$61.0 | 2023-09-16 | ||
| Enamine | EN300-1984947-0.1g |
2-chloro-5-(hydrazinylmethyl)pyridine |
1057670-48-0 | 0.1g |
$89.0 | 2023-09-16 | ||
| Enamine | EN300-1984947-0.25g |
2-chloro-5-(hydrazinylmethyl)pyridine |
1057670-48-0 | 0.25g |
$128.0 | 2023-09-16 | ||
| Enamine | EN300-1984947-0.5g |
2-chloro-5-(hydrazinylmethyl)pyridine |
1057670-48-0 | 0.5g |
$241.0 | 2023-09-16 |
2-Chloro-5-(hydrazinylmethyl)pyridine Related Literature
-
Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
-
Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
-
José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
-
4. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
-
Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
Additional information on 2-Chloro-5-(hydrazinylmethyl)pyridine
2-Chloro-5-(hydrazinylmethyl)pyridine: A Comprehensive Overview
The compound 2-Chloro-5-(hydrazinylmethyl)pyridine, identified by the CAS number 1057670-48-0, is a significant molecule in the field of organic chemistry and pharmacology. This compound belongs to the class of pyridine derivatives, which are widely studied due to their versatile applications in drug design, agrochemicals, and materials science. The structure of 2-Chloro-5-(hydrazinylmethyl)pyridine consists of a pyridine ring substituted with a chlorine atom at position 2 and a hydrazinylmethyl group at position 5, making it a unique derivative with potential for further functionalization.
Recent studies have highlighted the importance of pyridine derivatives in medicinal chemistry, particularly as scaffolds for developing bioactive molecules. The substitution pattern in 2-Chloro-5-(hydrazinylmethyl)pyridine allows for the exploration of various biological activities, including antioxidant, anti-inflammatory, and anticancer properties. Researchers have demonstrated that the hydrazinylmethyl group can act as a reactive site for conjugation with other bioactive moieties, enhancing the compound's therapeutic potential.
In terms of synthesis, 2-Chloro-5-(hydrazinylmethyl)pyridine can be prepared through a variety of methods, including nucleophilic substitution and coupling reactions. One common approach involves the reaction of 2-chloropyridine with hydrazine derivatives under appropriate conditions to introduce the hydrazinylmethyl group at position 5. The optimization of these synthetic routes has been a focus of recent research, with studies emphasizing the importance of reaction conditions, such as temperature and solvent choice, in achieving high yields and purity.
The application of computational chemistry tools has further enhanced our understanding of the properties of 2-Chloro-5-(hydrazinylmethyl)pyridine. Molecular modeling studies have provided insights into the compound's electronic structure, which is critical for predicting its reactivity and bioavailability. These studies have also revealed that the chlorine substituent at position 2 plays a significant role in modulating the electronic environment of the pyridine ring, thereby influencing its interaction with biological targets.
One area where 2-Chloro-5-(hydrazinylmethyl)pyridine has shown particular promise is in the development of anticancer agents. Recent research has demonstrated that this compound exhibits selective cytotoxicity against various cancer cell lines, suggesting its potential as a lead compound for anticancer drug development. Additionally, studies have explored its ability to inhibit key enzymes involved in cancer progression, such as kinases and proteases.
Beyond its therapeutic applications, 2-Chloro-5-(hydrazinylmethyl)pyridine has also been investigated for its role in agrochemicals. Its ability to interact with plant pathogens has led to exploratory studies on its potential as an antifungal or insecticidal agent. These findings underscore the versatility of pyridine derivatives in addressing diverse challenges across different fields.
In conclusion, 2-Chloro-5-(hydrazinylmethyl)pyridine, with its unique structural features and promising biological activities, represents a valuable molecule for further research and development. As advancements in synthetic methodologies and computational tools continue to evolve, this compound is poised to play an increasingly important role in the creation of novel therapeutic agents and agrochemicals.
1057670-48-0 (2-Chloro-5-(hydrazinylmethyl)pyridine) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)